Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Loureirin B can downregulate the expression of fibrosis-related molecules by regulating MMPs and TIMPs levels, inhibit scar fibroblast proliferation and suppress TGF-β1-induced fibrosis, during which TGF-β1/Smad2/3 pathway is likely involved.
パッケージサイズ | 在庫状況 | 単価(税別) | |||
---|---|---|---|---|---|
サンプルについてお問い合わせ | |||||
1 mg | 在庫あり | ¥ 15,000 | |||
5 mg | 在庫あり | ¥ 34,000 | |||
10 mg | 在庫あり | ¥ 50,000 | |||
25 mg | 在庫あり | ¥ 85,000 | |||
50 mg | 在庫あり | ¥ 125,000 | |||
100 mg | 在庫あり | ¥ 178,000 | |||
1 mL * 10 mM (in DMSO) | 在庫あり | ¥ 36,500 |
分子量 | 316.35 |
分子式 | C18H20O5 |
CAS No. | 119425-90-0 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 150 mg/mL (474.16 mM)
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Loureirin B 119425-90-0 MAPK Membrane transporter/Ion channel Metabolism PAI-1 ERK Potassium Channel JNK Inhibitor inhibit KcsA Plasminogen activator inhibitor-1 Extracellular signal regulated kinases inhibitor